echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Toothaches can cause and aggravate rheumatoid arthritis, and this bacteria is involved!

    Toothaches can cause and aggravate rheumatoid arthritis, and this bacteria is involved!

    • Last Update: 2022-09-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    *For medical professional reading reference only


    Clinical knowledge points that rheumatologists cannot miss

    The People's Health Publishing House "Oral Science 9th Edition" clearly stated that periodontitis may cause and aggravate rheumatoid arthritis (RA), which may be related to the periodontitis bacteria prompting the immune system to produce anti-CCP antibodies.



    At present, many studies have supported a close relationship between periodontitis and RA in terms of pathological manifestations, genetic studies, pathogenesis, and clinical evidence, and that periodontitis may be a pathogenic factor in the pathogenesis of RA, and vice versa


    Part2: Does Porphyromonas gingivalis increase the prevalence of RA?


    ▎The square believes that:


    • Higher serum levels of Porphyromonas gingivalis may be an important marker of aggressive periodontal disease


      • A study from the United States reported a positive association between Porphyromonas gingivalis and periodontal disease, the most effective predictor of periodontal disease in adolescents


        • Several studies have demonstrated that Porphyromonas gingivalis can cause the human immune system to react with it to produce anti-CCP antibodies, which can promote the occurrence of RA in genetically susceptible individuals


          • Several studies have shown that RA patients have developed anti-CCP antibodies 5 years before diagnosis


            • Porphyromonas gingivalis induces an inflammatory response, and this bacterium is more likely to invade healthy and inflamed tissues than other bacteria such as Candida


              Seror et al.


              ▎New angle:

              The study by Ziebolz et al.




              A newly published meta-analysis on July 18, 2022 answers this question


              Figure 1: Main characteristics of studies selected for the meta-analysis

              The 28 studies represented 28 independent populations
              .

              The results of the meta-analysis showed that individuals exposed to Porphyromonas gingivalis had a significantly increased risk of developing rheumatoid arthritis, with an overall pooled OR of 1.
              86 (95%CI 1.
              43-2.
              43)

              Figure 2: Forest plot of binary data for association between P.
              gingivalis and RA
              .

               

              Subgroup analysis showed that the combined OR values ​​from European (OR=2.
              17, 95%CI 1.
              46-3.
              22) and North American (OR=2.
              50, 95%CI 1.
              23-5.
              08) populations were significantly higher than those from Asian populations (OR=1.
              11, 95%) CI 1.
              03~1.
              20)
              .

               

              Figure 3: Results of subgroup analysisIn addition, the sensitivity analysis of the 28 included studies also supports the reliability and robustness of the above conclusions
              .
              In conclusion, the conclusions of the above meta-analysis suggest that P.
              gingivalis exposure is a potential risk factor for RA
              .

              Prompt diagnosis and management decisions of Porphyromonas gingivalis antimicrobial therapy may prevent the onset and exacerbation of RA
              .

              More research is still needed to confirm the causal relationship between P.
              gingivalis exposure and the onset of RA
              .

              Summarize

              1.
              Periodontitis bacteria can prompt the immune system to produce anti-CCP antibodies, which in turn promotes the occurrence of RA
              .
              2.
              Maintaining oral hygiene, frequent scaling and early treatment when periodontal disease occurs may prevent the occurrence of RA
              .
              3.
              Rheumatologists should pay more attention to the periodontal problems of RA patients.
              Periodontal problems are more common in RA patients, and periodontal treatment may improve the symptoms and signs of RA to a certain extent
              .

              references:

              [1] Zhang Zhiyi.
              "Stomatology.
              The 9th Edition".
              Beijing: People's Health Publishing House, 2018

              [2] Gómez-Bañuelos E, Mukherjee A, Darrah E, Andrade F.
              Rheumatoid Arthritis-Associated Mechanisms of Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans.
              J Clin Med.
              2019;8(9):1309.
              Published 2019 Aug 26.
              doi:10.
              3390 /jcm8091309 

              [3] Johansson L, Sherina N, Kharlamova N, et al.
              Concentration of antibodies against Porphyromonas gingivalis is increased before the onset of symptoms of rheumatoid arthritis [published correction appears in Arthritis Res Ther.
              2016 Nov 4;18(1):257 ].
              Arthritis Res Ther.
              2016;18(1):201.
              Published 2016 Sep 7.
              doi:10.
              1186/s13075-016-1100-4

              [4] Li Y, Guo R, Oduro PK, et al.
              The Relationship Between Porphyromonas Gingivalis and Rheumatoid Arthritis: A Meta-Analysis.
              Front Cell Infect Microbiol.
              2022;12:956417.
              Published 2022 Jul 18.
              doi:10.
              3389/fcimb .
              2022.
              956417

              Where can I find more rheumatism clinical knowledge?
              Come and have a look at the "Doctor Station"👇

              Source of this article: Rheumatism and Immunity Channel of the Medical Community Author of this article: Yao Xiaoyan Review of this
              article : Deputy Chief Physician Chen Xinpeng
              , 1.
              Clinical practical skills, misdiagnosed cases, clinical medication, interesting content of rheumatology and immunology; 2.
              Interesting diagnosis and treatment stories of rheumatology immunologists; 3.
              Major progress in the field of rheumatology and immunization; 4.
              Others (rheumatology immunologists feel content of interest)
              .
              Contributions are welcome to share! We will provide you with competitive royalties and a platform to showcase your talents
              .

              Submission email: yanjin@yxj.
              org.
              cn (reply to manuscripts) The medical community strives for the accuracy and reliability of its published content when it is approved, but does not regard the timeliness of the published content and the accuracy of the cited materials (if any) and completeness, etc.
              , and do not assume any responsibility for the outdated content, possible inaccuracy or incompleteness of the cited information
              .

              Relevant parties are requested to check separately when adopting or using it as a basis for decision-making
              .

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.